LOW-GRADE UPPER TRACT UROTHELIAL CARCINOMA
Clinical trials for LOW-GRADE UPPER TRACT UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOW-GRADE UPPER TRACT UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for LOW-GRADE UPPER TRACT UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy instilled directly into kidney shows promise for rare cancer
Disease control Recruiting nowThis early-stage trial tests a gene therapy drug called nadofaragene firadenovec, which is instilled directly into the kidney's drainage system. It aims to treat low-grade upper tract urothelial cancer (LG-UTUC) by delivering a gene that helps the body fight cancer cells. The stu…
Matched conditions: LOW-GRADE UPPER TRACT UROTHELIAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Ferring Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 08:34 UTC
-
New pill aims to wipe out rare bladder tumors without surgery
Disease control Recruiting nowThis study tests a new oral drug, dabogratinib, in 230 adults with a rare, low-grade cancer of the upper urinary tract. The goal is to see if the drug can make tumors disappear completely within six months. Participants must have a specific genetic marker (FGFR3) and a visible tu…
Matched conditions: LOW-GRADE UPPER TRACT UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated May 20, 2026 11:56 UTC